RG
Gedeon Richter PLC
RGEDF · OTC
$39.69 +1.98% (+$0.77)
1M -11.07%
Market Cap 2.28T Ft
P/E Ratio 10.64x
Div. Yield 5.51%
ROE 15.52%
Bulios Fair Price
$54.9
38.3% upside
Current Price
$39.69
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RGEDF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
96 /100
Cheap P/FCF 8.33x
P/E 10.64x
P/B 1.68x
Growth
72 /100
Growing FCF growth 29.87%
EPS growth 14.82%
Book val. growth 9.81%
Profitability
100 /100
Strong Op. margin 35.39%
Gross margin 68.47%
FCF margin 29.84%
Quality
80 /100
Excellent ROA 12.67%
ROIC 17.84%
Asset turnover 0.54x
Debt
88 /100
Low Int. coverage 3.27x
Debt/Equity 0.01x
Net debt/EBITDA -0.66x
Stability
74 /100
Stable EPS volatility 30.30%
Beta 0.34x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RGEDF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Gabor Orban
Employees
11,955
Headquarters
Budapest
Upcoming events
10 NOV
Earnings
Upcoming earnings report